Proteomics

Dataset Information

0

The urinary proteome differs with the presence and type of breast cancer


ABSTRACT: Despite the advancements in screening and treatment, the incidence of breast cancer (BC) and associated mortalityare projected to increase. Therefore, developing a companion diagnostic for BC remains important. To explore the urinary proteome for potential biomarkers for BC.  A total of 130 participants were recruited for this study which categorised into four groups; (1) newly diagnosed breast cancer (BC) n=46, (2) benign breast disease (BBD) n=36, (3) symptom control (SC) n=30 and (4) healthy control (HC) n=18. The BC class sub-divided in pre-invasive: ductal carcinoma in situ (DCIS) (n=3), invasive ductal carcinoma (IDC) (n=23) and IDC accompanied DCIS (n=8) classes. Purified urinary proteins were analysed using a bottom-up data dependent acquisition proteomics approach. Protein identifications and abundances were generated using Thermo Scientific TM Proteome Discoverer TM with statistical analyses were performed via open-source software platforms and databases; MetaboAnalyst v6.0, DAVID and STRING v12.0.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Urine

DISEASE(S): Breast Cancer

SUBMITTER: Nur Aimi Aliah Zainurin  

LAB HEAD: Luis Mur

PROVIDER: PXD061502 | Pride | 2025-12-15

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
260424_Breast_Cancer_Urine.msf Msf
P100_068YGC_BBD.raw Raw
P101_069YGC_BBD.raw Raw
P102_072YGC_BBD.raw Raw
P103_073YGC_BBD.raw Raw
Items per page:
1 - 5 of 131
altmetric image

Publications

The Urinary Proteome Differs with the Presence and Type of Breast Cancer.

Zainurin Nur Aimi Aliah NAA   Morphew Russell M RM   Ganti Alekhya A   Ivanova Dimitra D   Gate Tim T   Tench Helen H   Phillips Helen H   Pennick Mandana M   Mur Luis A J LAJ  

Journal of proteome research 20251103 12


Despite advancements in screening and treatment, the incidence of breast cancer (BC) and associated mortality are projected to increase. Therefore, developing a companion diagnostic for BC remains important. Herein, we explore the urinary proteome for biomarkers of BC: 130 urine samples from (1) newly diagnosed breast cancer (BC), <i>n</i> = 46, (2) benign breast disease (BBD), <i>n</i> = 36, (3) symptom control (SC), <i>n</i> = 30, and (4) healthy control (HC), <i>n</i> = 18. The BC class inclu  ...[more]

Similar Datasets

2023-03-10 | PXD021819 | Pride
2012-05-10 | E-GEOD-35019 | biostudies-arrayexpress
2024-12-03 | E-MTAB-14655 | biostudies-arrayexpress
2023-07-20 | PXD037004 | Pride
2022-08-30 | PXD031347 | Pride
2025-01-14 | PXD046269 | Pride
2012-12-01 | E-GEOD-35901 | biostudies-arrayexpress
2025-05-06 | PXD045164 | Pride
2024-05-10 | PXD037488 | Pride
2025-11-17 | PXD062276 | Pride